GeneBio Systems
Recombinant ANGPTL3 Monoclonal Antibody
Recombinant ANGPTL3 Monoclonal Antibody
SKU:AN301438L
Couldn't load pickup availability
Size::50μL
Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping:Ice bag
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Monoclonal Antibodies;Recombinant Antibodies
Abbreviation:ANGPTL3
Target Synonym:ANG;UNQ;PRO;FHBL;Angiopoietin;angiopoietin like;Angiopoietin-like protein;Angiopoietin-related protein;ANGPT;ANGPTL;ANGPTL3;ANG-5;ANGPT5;ANL3;FHBL2;angiopoietin like 3;Angiopoietin-5;Angiopoietin-like protein 3;Angiopoietin-related protein 3;ANL;UNQ153;PRO179;ANG-5;ANGPT5;ANL3;FHBL2
Research Areas:Cardiovascular;Signal Transduction;Metabolism
Conjugation:Unconjugated
Host:Rabbit
Species reactivity:Human;Mouse
Application:WB;IHC;IF
Isotype:IgG,κ
Clonality:Monoclonal;Recombinant
Clone NO.:A133
UNIProt ID:Q9Y5C1
Accession:
Background:Acts in part as a hepatokine that is involved in regulation of lipid and glucose metabolism. Proposed to play a role in the trafficking of energy substrates to either storage or oxidative tissues in response to food intake. Has a stimulatory effect on plasma triglycerides (TG), which is achieved by suppressing plasma TG clearance via inhibition of LPL activity. The inhibition of LPL activity appears to be an indirect mechanism involving recruitment of proprotein convertases PCSK6 and FURIN to LPL leading to cleavage and dissociation of LPL from the cell surface; the function does not require ANGPTL3 proteolytic cleavage but seems to be mediated by the N-terminal domain, and is not inhibited by GPIHBP1. Can inhibit endothelial lipase, causing increased plasma levels of high density lipoprotein (HDL) cholesterol and phospholipids. Can bind to adipocytes to activate lipolysis, releasing free fatty acids and glycerol. Suppresses LPL specifically in oxidative tissues which is required to route very low density lipoprotein (VLDL)-TG to white adipose tissue (WAT) for storage in response to food; the function may involve cooperation with circulating, liver-derived ANGPTL8 and ANGPTL4 expression in WAT.
Concentration:1 mg/mL
Immunogen:Synthetic peptide derived from ANGPTL3 anti
Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification method:Protein A purified
Dilution:WB 1:500-1:1000;IHC 1:50-1:100;IF 1:50
Calculated MW:54 kDa
ObservedMW:54 kDa
